Lilly announces procurement agreement with European Commission to supply bamlanivimab and etesevimab together for the treatment of confirmed COVID-19

21 September 2021 - Joint Procurement Agreement enables European countries to purchase bamlanivimab and etesevimab directly from Lilly, in varying ...

Read more →

Pharmacist substitution of PBS medicines without a prescription during shortages (Serious Scarcity Substitution Instrument)

18 September 2021 - Where a Serious Scarcity Substitution Instrument has been issued by the TGA, community pharmacists can substitute specific ...

Read more →

Lilly to supply 388,000 doses of etesevimab to U.S. Government for treatment of COVID-19

15 September 2021 - Additional doses of etesevimab will be paired with existing bamlanivimab purchased by the U.S. Government ...

Read more →

Regeneron announces new U.S. Government agreement to purchase additional doses of REGEN-COV (casirivimab and imdemivab) antibody cocktail

14 September 2021 - New agreement for 1.4 million doses of REGEN-COV, brings total purchased by the U.S. government to nearly ...

Read more →

Access Consortium: alignment with ICMRA consensus on immunobridging for authorising new COVID-19 vaccines

14 September 2021 - Placebo controlled disease outcome trial data are the gold standard for authorising vaccines. However, for COVID-19 ...

Read more →

Limiting the impact on Kiwis as API leaves the NZ market

14 September 2021 - PHARMAC is working hard to limit the impact on over 1 million Kiwis who currently take ...

Read more →

TLV is commissioned to secure access to antibiotics

13 September 2021 - TLV, the Swedish Public Health Agency and the Medical Products Agency have been commissioned by the Government ...

Read more →

UK terminates Valneva COVID-19 vaccine supply agreement

13 September 2021 - The UK government has terminated its supply agreement with French firm Valneva for its COVID-19 vaccine ...

Read more →

Joint statement: supply allocations of intravenous tocilizumab (Actemra) during serious shortage

8 September 2021 - Roche, the sponsor of tocilizumab (Actemra), notified the TGA of shortages of multiple presentations of tocilizumab products ...

Read more →

Four million Pfizer doses arrive to super-charge vaccine roll out

6 September 2021 - Four million extra Pfizer-BioNTech (Pfizer) vaccine doses will begin arriving in Australia in days following a historic ...

Read more →

New Zealand’s tocilizumab supply to be paused

6 September 2021 - PHARMAC has today announced that Roche, the global pharmaceutical company which provides tocilizumab, will not provide New ...

Read more →

Biogen offers free Alzheimer's drug as Medicare payment uncertainty remains

30 August 2021 - Biogen is providing its controversial and expensive new Alzheimer's drug free of charge for some patients amid ...

Read more →

Increase in vaccine manufacturing capacity for COVID-19 vaccines from BioNTech/Pfizer and Moderna

24 August 2021 - EMA’s CHMP has adopted recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the ...

Read more →

Booster shots ‘make a mockery of vaccine equity,’ the WHO’s Africa director says

19 August 2021 - The Africa director at the World Health Organization, Dr. Matshidiso Moeti, criticized the decisions by some ...

Read more →

WHO calls on Roche to ensure fair access to COVID-19 drug amid shortage

18 August 2021 - The World Health Organization called on Wednesday on Roche to ensure fair distribution of its arthritis ...

Read more →